[Preliminary evaluation of the induction chemotherapy PBM (cisplatin, bleomycin, methotrexate) in the combined treatment of patients with advanced cancer of the head and neck].
Korzeniowski
S
S
Migdał
K
K
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D012074:Remission Induction
D001761:Bleomycin; D002945:Cisplatin; D008727:Methotrexate
Wstepna ocena skuteczności indukcyjnej chemioterapii PBM (cisplatin, bleomycin, methotrexate) w skojarzonym leczeniu chorych na zaawansowanego raka terenu głowy i szyi.